
|Videos|March 15, 2016
SGLT2 Inhibitors and Risk for Ketoacidosis and Urinary Tract Infections
Susan Cornell, PharmD, CDE, FAPhA, FAADE, describes the risks for ketoacidosis and serious urinary tract infection associated with use of SGLT2 inhibitors.
Advertisement
Susan Cornell, PharmD, CDE, FAPhA, FAADE, describes the risks for ketoacidosis and serious urinary tract infection associated with use of SGLT2 inhibitors.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Pharmacist’s Guide to Modern Menopause Management in 2026
2
Oncology Pulsepoint: How Updated Immunotherapy Guidelines are Changing Renal Cell Carcinoma Care
3
Translation: A Pharmacist’s Greatest Skill
4
Time of Day Doesn't Affect Flu Vaccine Effectiveness, Large Cohort Study Finds
5










































































































